NPM1 and acute myeloid leukemia: In a third study on 252 mNPM1 AML [41,42], the persistence of high levels of NPM1 mutations were significantly correlated with survival at each of four time-points of monitoring (18–60 days, 61–120 days, 121–365 days, >365 days).